363166-11-4

Basic information

• Product Name: Benzaldehyde, 4-bromo-3,5-diethoxy-
• CAS NO: 363166-11-4
• Molecular Formula: C11H13BrO3
• Molecular Weight: 273.126
• Mol File: 363166-11-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 4-bromo-3,5-diethoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 4-bromo-3,5-diethoxy-(363166-11-4)
• EPA Substance Registry System: Benzaldehyde, 4-bromo-3,5-diethoxy-(363166-11-4)

Safety Data

• Hazardous Substances Data: 363166-11-4(Hazardous Substances Data)

Upstream product

• 149517-92-0 ethyl 4-bromo-3,5-diethoxybenzoate 
• 16534-12-6 3,5-dihydroxy-4-bromobenzoic acid 
• 363166-41-0 4-bromo-3,5-diethoxybenzoic acid 
• 363166-42-1 (4-bromo-3,5-diethoxyphenyl)methanol 

Relevant articles and documents

SPIRO AZETIDINE ISOXAZOLE DERIVATIVES AND THEIR USE AS SSTR5 ANTAGONISTS

Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.

PYRIDINE, QUINOLINE AND PYRIMIDINE DERIVATIVES

This invention is concerned with compounds of the formula wherein A, R1 to R5 are as defined in the specification and G is a pyridine, quinoline or pyrimidine group as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

Pyrimidine, quinazoline, pteridine and triazine derivatives

This invention is concerned with compounds of the formula wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.